Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Merz Pharma designs novel modulators of mGlu5 receptors

July 24, 2012

New metabotropic glutamate receptor antagonists synthesized at Novartis

July 23, 2012

Sigma-Tau presents new HSP 90 inhibitors

July 23, 2012

The Medicines Company patents new agents for thrombotic disorders

July 23, 2012

Hong Kong researchers patent new agents for cancer

July 23, 2012

German researchers design new mGlu5 receptor modulators

July 23, 2012

Boehringer Ingelheim presents novel B-raf inhibitors

July 23, 2012

Novel bile acid receptor agonists presented by IRM

July 20, 2012

Novel antivirals disclosed by Abbott

July 20, 2012

New antisense oligonucleotides designed at miRagen Therapeutics

July 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...